EPT

1. 2026-10-19issueIssued emergency
2. 2026-10-19issueIssued info_card
3. 2026-10-19issueIssued notice
4. 2026-09-07srcMetabolite markers for three synthetic tryptamines N-ethyl-N-propyltryptamine, 4-hydroxy-N-ethyl-N-propyltryptamine, and 5-methoxy-N-ethyl-N-propyltryptamine
5. 2026-09-07srcSerotonin toxicity of serotonergic psychedelics
6. 2026-09-07srcDimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
7. 2026-09-07srcIdentification of six tryptamine derivatives as designer drugs in illegal products
8. 2026-09-07srcPharmacokinetics of N,N-dimethyltryptamine in Humans
9. 2026-09-07srcSafety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances
10. 2026-09-07srcSerotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.
11. 2026-09-07srcPsychedelic-related deaths in England, Wales and Northern Ireland (1997-2022)
12. 2026-09-07srcDetermination of tryptamine analogs in whole blood by 96-well electromembrane extraction and UHPLC-MS/MS
13. 2026-09-07srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
14. 2026-09-07srcStructure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties
15. 2026-09-07srcN,N-Dimethyltryptamine Forms Oxygenated Metabolites via CYP2D6 - An In Vitro Investigation
16. 2026-09-07srcDMT analogues: N-ethyl-N-propyl-tryptamine and N-allyl-N-methyltryptamine as their hydro-fumarate salts
17. 2026-09-07srcDiscriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
18. 2026-09-07srcTolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
19. 2026-09-07srcPharmacologic Activity of Substituted Tryptamines at 5-HT2A, 5-HT2C, 5-HT1A Receptors and SERT
20. 2026-09-07srcThermodynamics of peptide and non-peptide interactions with the human 5HT1a receptor.
21. 2026-09-07srcRecreational use, analysis and toxicity of tryptamines.
22. 2026-09-07srcDPT as an Adjunct in Brief Psychotherapy with Cancer Patients
23. 2026-09-07srcToxicology and Analysis of Psychoactive Tryptamines.
24. 2026-09-07srcBinding properties of dipropyltryptamine at the human 5-HT1a receptor.
25. 2026-09-07srcBehavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity.
26. 2026-09-07srcHallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
27. 2026-09-07srcObliterating the Head: A Retrospective (EPT, DPT, DMT, MET, MPT, MiPT, 5-MeO-MiPT & 5-MeO-EiPT comparative report)
28. 2026-09-07srcEPT experience reports index
29. 2026-09-07srcEthylpropyltryptamine - Wikipedia
30. 2026-09-07srcTotal Clarity (EPT & Cannabis experience report)
31. 2026-09-07srcEPT - PsychonautWiki
32. 2026-09-04issueIssued emergency
33. 2026-09-04issueIssued info_card
34. 2026-09-04issueIssued notice
35. 2026-06-04proposal3 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
36. 2026-06-04publicationPublication — backfill
37. 2026-06-04proposal25 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
38. 2026-05-10revisionRevision 1
39. 2026-05-10absenceSearched PubMed for "EPT N-ethyl-N-propyltryptamine psychedelic tryptamine" — no results
40. 2026-05-10absenceSearched ClinicalTrials.gov for "EPT ethylpropyltryptamine tryptamine psychedelic" — no results
41. 2026-05-10genGeneration — pipeline-v5 · with 5 morepipeline-v5
42. 2026-05-10rungeneration run

The same entries, as forms: six forms.